Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein
10.1038/nm0497-414
Crossref journal-article
Springer Science and Business Media LLC
Nature Medicine (297)
Bibliography

Benimetskaya, L., Loike, J. D., Khaled, Z., LoiKe, G., Silverstein, S. C., Cao, L., Khoury, J. E. L., CaI, T.-Q., & Stein, C. A. (1997). Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein. Nature Medicine, 3(4), 414–420.

Authors 9
  1. Lyuba Benimetskaya (first)
  2. John D. Loike (additional)
  3. Zahangir Khaled (additional)
  4. Gila LoiKe (additional)
  5. Samuel C. Silverstein (additional)
  6. Long Cao (additional)
  7. Joseph E.L. Khoury (additional)
  8. Tian-Quan CaI (additional)
  9. C.A. Stein (additional)
References 42 Referenced 198
  1. Dean, N. & McKay, R. Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc. Notl. Acad. Sci. USA 91, 11762–11766 (1994). (10.1073/pnas.91.24.11762) / Proc. Notl. Acad. Sci. USA by N Dean (1994)
  2. Ratajczak, M. et al. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides. Proc. Natl. Acad. Set. USA 89, 11823–11827 (1992). (10.1073/pnas.89.24.11823) / Proc. Natl. Acad. Set. USA by M Ratajczak (1992)
  3. Cotter, F. et al. Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model. Oncogene 9, 3049–3055 (1994). / Oncogene by F Cotter (1994)
  4. Shoji, Y. et al. Mechanism of cellular uptake of modified oligonucleotides containing methylphosphonate linkage. Nucleic Acids Res. 19, 5543–5550 (1991). (10.1093/nar/19.20.5543) / Nucleic Acids Res. by Y Shoji (1991)
  5. Yakubov, L.A. et al. Mechanism of oligonucleotide uptake by cells: Involvement of specific receptors?. Proc Natl. Acad. Sci. USA 86, 6454–6458 (1989). (10.1073/pnas.86.17.6454) / Proc Natl. Acad. Sci. USA by LA Yakubov (1989)
  6. Tonkinson, J.L. & Stein, C.A. Patterns of intra cellular compartmentalization, trafficking and acidification of 5′-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells. Nucleic Acids Res. 22, 4268–4275 (1994). (10.1093/nar/22.20.4268) / Nucleic Acids Res. by JL Tonkinson (1994)
  7. Loke, S.L. et al. Characterization of oligodeoxynucleotide transport into living cells. Proc. Natl. Acad. Sci. USA 86, 3474–3478 (1989). (10.1073/pnas.86.10.3474) / Proc. Natl. Acad. Sci. USA by SL Loke (1989)
  8. Beltinger, C. et al. Binding, uptake and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J. Clin. Invest. 95, 1814–1823 (1995). (10.1172/JCI117860) / J. Clin. Invest. by C Beltinger (1995)
  9. Rappaport, J. et al. Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapy. Kidneyv Int. 47, 1462–1469 (1995). (10.1038/ki.1995.205) / Kidneyv Int. by J Rappaport (1995)
  10. Guvakova, M.A. et al. Phosphorothioate oligodeoxynucleotides bind to basic fi-broblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extra Cellular matrix. J. Biol. Chem. 270, 2620–2627 (1995). (10.1074/jbc.270.6.2620) / J. Biol. Chem. by MA Guvakova (1995)
  11. Kimura, Y. et al. Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK Cell activity and induce IFN. J. Biochem. 116, 991–994 (1994). (10.1093/oxfordjournals.jbchem.a124658) / J. Biochem. by Y Kimura (1994)
  12. Coombe, D., Watt, S.M. & Parish, C.R. Mac-1 (CD11b/CD18) and CD45 mediate the adhesion of hematopoietic progenitor cells to stromal cell elements via recognition of stromal heparan sulfate. Blood 84, 739–752 (1994). (10.1182/blood.V84.3.739.739) / Blood by D Coombe (1994)
  13. Diamond, M., Alon, R., Alon, R., Quinn M. & Springer, T. Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD18). J. Cell Biol. 130, 1473–1482 (1995) (10.1083/jcb.130.6.1473) / J. Cell Biol. by M Diamond (1995)
  14. Loike, J. et al. CD11 c/CDI 8 on neutrophils recognizes a domain at the N terminus of the Aa chain of fibrinogen. Proc. Natl. Acad. Sci. USA 88, 1044–1048 (1991). (10.1073/pnas.88.3.1044) / Proc. Natl. Acad. Sci. USA by J Loike (1991)
  15. Wright, S. et al. Complement receptor type three (CD11 b/CDI 8) of human poly-morphonuclear leukocytes recognizes fibrinogen. Proc Natl. Acad. Sci. USA 85, 7734–7738 (1988). (10.1073/pnas.85.20.7734) / Proc Natl. Acad. Sci. USA by S Wright (1988)
  16. Wright, S. et al. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. Proc. Natl. Acad. Sci. USA 80, 5699–5703 (1983). (10.1073/pnas.80.18.5699) / Proc. Natl. Acad. Sci. USA by S Wright (1983)
  17. Diamond, M., Staunton, D., Marlin, S. & Springer, T. Binding of the integrin Mac-1 (CD11 b/CDI 8) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65, 961–971 (1991). (10.1016/0092-8674(91)90548-D) / Cell by M Diamond (1991)
  18. Alteri, D. & Edgington, T. The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J. Biol. Chem. 263, 7007–7015 (1988). (10.1016/S0021-9258(18)68596-5) / J. Biol. Chem. by D Alteri (1988)
  19. Loike, J. etal. Fibrin regulates neutrophil migration in response to interleukin 8 and LTB4, TNF or fMLP. J. Exp. Med. 181, 1763–1772 (1995). (10.1084/jem.181.5.1763) / J. Exp. Med. by J Loike (1995)
  20. Mohri, H. & Ohkubo, T. Fibrinogen binds to heparin: The relationship of the binding of other adhesive proteins to heparin. Arch. Biochem. Biophys. 303, 27–31 (1993). (10.1006/abbi.1993.1251) / Arch. Biochem. Biophys. by H Mohri (1993)
  21. Bates, E., Ferrante, A., Harvey, D. & Poulos, A. Polyunsaturated fatty acids increase neutrophil adherence and integrin receptor expression. J. Leukocyte Biol. 53, 420–426 (1993). (10.1002/jlb.53.4.420) / J. Leukocyte Biol. by E Bates (1993)
  22. Diamond M. et al The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 120, 1031–1043 (1993). (10.1083/jcb.120.4.1031) / J. Cell Biol. by M Diamond (1993)
  23. Yakubov, L. et al. Oligodeoxynucleotides interact with recombinant CD4 at multiple sites. J. Biol. Chem. 268, 18818–18823 (1993). (10.1016/S0021-9258(17)46701-9) / J. Biol. Chem. by L Yakubov (1993)
  24. Higgins, K. et al. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. USA 90, 9901–9905 (1993). (10.1073/pnas.90.21.9901) / Proc. Natl. Acad. Sci. USA by K Higgins (1993)
  25. Cheng, Y. & Prusoff, W. Relationship between the inhibition constant and the concentration of inhibitor which causes 50% inhibition (ISO) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099–3108 (1973). (10.1016/0006-2952(73)90196-2) / Biochem. Pharmacol. by Y Cheng (1973)
  26. Stein C.A. Suramin: A novel antineoplastic agent with multiple potential mechanisms of action. Cancer Res. 52, 2239–2248 (1993). / Cancer Res. by CA Stein (1993)
  27. El Khoury, J. et al. Macrophages adhere to glucose-modified fibronectin and collagen IV via their scavenger receptors. J Biol. Chem. 269, 10197–10200 (1994). (10.1016/S0021-9258(17)34043-7) / J Biol. Chem. by J El Khoury (1994)
  28. Fraser, I., Hughes, D. & Cordon, S. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murin scavenger receptor. Nature 364, 343–346 (1993). (10.1038/364343a0) / Nature by I Fraser (1993)
  29. El Khoury J. et al. Scavenger receptor-meiated adhension of microglia to β-amyloid fibrils and secretion of reactive oxygen species. Nature 382, 716–719 (1996). (10.1038/382716a0) / Nature by J El Khoury (1996)
  30. Fuortes, M., Jen, W. & Nathan, C. Adhesion-dependent protein tyrosine phosphorylation in neutrophils treated with tumor necrosis factor. J. Cell. Biol. 120, 777–784 (1993). (10.1083/jcb.120.3.777) / J. Cell. Biol. by M Fuortes (1993)
  31. Zhou, L. et al. Differential ligand binding specificities of recombinant CD11b/CD18 integrin l-domain. J. Biol. Chem. 269, 17075–17079 (1994). (10.1016/S0021-9258(17)32522-X) / J. Biol. Chem. by L Zhou (1994)
  32. Lee, J., Riew, P., Arnaout, M. & Liddington, R. Crystal structure of the A domain from the a subunit of integrin CR3 (CD11 b/CDI 8). Cell 80, 631–638 (1995). (10.1016/0092-8674(95)90517-0) / Cell by J Lee (1995)
  33. Stein C.A. et al. Dynamics of the internalization of phosphodiester oligodeoxynu cleotides in HL60 cells. Biochemistry 32, 4855–4861 (1993). (10.1021/bi00069a022) / Biochemistry by CA Stein (1993)
  34. Krieg, A. et al. Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible. Antisense Res. Dev. 1, 161–171 (1991). (10.1089/ard.1991.1.161) / Antisense Res. Dev. by A Krieg (1991)
  35. Zhao, Q. et al. Comparison of cellular binding and uptake of antisense phosphodi ester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 3, 53–66 (1993). (10.1089/ard.1993.3.53) / Antisense Res. Dev. by Q Zhao (1993)
  36. Zhao, Q. et al. Stage specific oligonucleotide uptake in murine bone marrow B-Cell precursors. Blood 84, 3660–3666 (1994). (10.1182/blood.V84.11.3660.bloodjournal84113660) / Blood by Q Zhao (1994)
  37. Graham, I., Anderson, D., Holers, V.M. & Brown, E. Complement receptor 3 (CR3, Mac-1, Integrin aM (32, CD11 b/CDI 8) is required for tyrosine phosphorylation of paxillin in adherent and nonadherent neutrophils. J. Cell. Biol. 127, 1139–1147 (1994). (10.1083/jcb.127.4.1139) / J. Cell. Biol. by I Graham (1994)
  38. Loike, J., Somes, M. & Silverstein, S. Creatine uptake, metabolism, and efflux in human monocytes and macrophages. Am. J. Physiol. 251, C128135 (1986). (10.1152/ajpcell.1986.251.1.C128) / American Journal of Physiology-Cell Physiology by J. D. Loike (1986)
  39. Cai, T. & Wright, S. Energetics of leukocyte integrin activation. J. Biol. Chem. 270, 14538–14365 (1995). / J. Biol. Chem. by T Cai (1995)
  40. Stein, C.A., Subasinghe C., Shinozuka, K. & Cohen, J. . Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res. 16, 3209–3221 (1988). (10.1093/nar/16.8.3209) / Nucleic Acids Res. by CA Stein (1988)
  41. Sambrook J., Fritsch E. & Maniatis T. Molecular Cloning: A Laboratory Manual. 10.66 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, (1989). / Molecular Cloning: A Laboratory Manual by J Sambrook (1989)
  42. Knorre, D., Vlassov, V., Zarytova, V. & Karpova, G. Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Chemical aspects. Adv. Enzyme Regul. 24, 277–300 (1985). (10.1016/0065-2571(85)90082-2) / Adv. Enzyme Regul. by D Knorre (1985)
Dates
Type When
Created 21 years ago (Aug. 18, 2004, 9:46 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:20 p.m.)
Indexed 3 weeks, 2 days ago (Aug. 2, 2025, 1:17 a.m.)
Issued 28 years, 4 months ago (April 1, 1997)
Published 28 years, 4 months ago (April 1, 1997)
Published Print 28 years, 4 months ago (April 1, 1997)
Funders 0

None

@article{Benimetskaya_1997, title={Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein}, volume={3}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/nm0497-414}, DOI={10.1038/nm0497-414}, number={4}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Benimetskaya, Lyuba and Loike, John D. and Khaled, Zahangir and LoiKe, Gila and Silverstein, Samuel C. and Cao, Long and Khoury, Joseph E.L. and CaI, Tian-Quan and Stein, C.A.}, year={1997}, month=apr, pages={414–420} }